|Bid||0.9720 x N/A|
|Ask||0.9730 x N/A|
|Day's Range||0.9710 - 0.9940|
|52 Week Range||0.8810 - 1.5250|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
As Americans brace themselves for year three of pandemic life, their mental health hits an all-time low, according to the Mental Health Index: U.S. Worker Edition. Most notably, PTSD, depression and addiction soar amid skyrocketing cases of Omicron. An alarming 1 in 4 American workers screened positive for post-traumatic stress disorder (PTSD) – up 54% in the past three months and up 136% when compared to pre-pandemic. Depression is surging – up 87% since fall (63% higher than before COVID19).
Total Brain, a mental health and brain performance monitoring and support platform, today announced that the company has signed a deal with Kerna Health, a leader in digital connected care. As part of the newly minted agreement, Kerna will integrate the Total Brain digital neurotech platform into the company's Behavioral Health Integration support solution. Under the terms of the non-exclusive deal, and as the partnership scales over the upcoming 12-18 months, Total Brain's assessment and self-c
Total Brain today announced that the company will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D) research data to Janssen Research & Development, LLC. The company will use Total Brain's iSPOT-D data to support clinical studies and precision drug development efforts to treat depression.